Genmab — Juli 2019
-
-
Genedata Biopharma Platform Adopted by Genmab to Streamline Biotherapeutics R&D Operations https://news.thomasnet.com/companystory/genedata-biopharma-platform-adopted-by-genmab-to-streamline-biotherapeutics-r-and-d-operations-40026954
-
Alt kan rykke ved estimaterne, men ingen regner jo med monopol til dara. WW MM marked estimeres af nogen til små 40 mia $ i 2024, så for at nå et topsalg på 8 mia $ i MM skal dara altså kun sætte sig på 1/5. https://www.grandviewresearch.com/press-release/global-multiple-myeloma-therapeutics-market
-
Revlimid solgte sidste år for 9,7 mia $ https://ir.celgene.com/press-releases/press-release-details/2019/Celgene-Reports-Fourth-Quarter-and-Full-Year-2018-Operating-and-Financial-Results/default.aspx
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind